Fiduciary Financial Group LLC Takes $315,000 Position in Option Care Health, Inc. $OPCH

Key Points

• Fiduciary Financial Group LLC invested $315,000 in Option Care Health, acquiring 9,848 shares during the second quarter.
• Insider transactions saw Director Norman L. Wright purchasing 3,411 shares, increasing his ownership by 28.21%, and Timothy P. Sullivan buying 20,000 shares, boosting his stake by 68.43%.
• Analysts have set a consensus price target of $35.75 for Option Care Health, with eight analysts recommending a Buy rating on the stock.

Fiduciary Financial Group LLC bought a new position in Option Care Health, Inc. (NASDAQ:OPCH - Free Report) during the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 9,848 shares of the company's stock, valued at approximately $315,000.

Several other hedge funds have also added to or reduced their stakes in OPCH. Durable Capital Partners LP bought a new stake in Option Care Health in the first quarter worth $122,905,000. Nuveen LLC bought a new stake in Option Care Health in the first quarter worth $70,965,000. Allspring Global Investments Holdings LLC boosted its holdings in Option Care Health by 6,525,926.1% in the first quarter. Allspring Global Investments Holdings LLC now owns 1,500,986 shares of the company's stock worth $52,459,000 after acquiring an additional 1,500,963 shares in the last quarter. Voloridge Investment Management LLC bought a new stake in Option Care Health in the fourth quarter worth $27,428,000. Finally, Fuller & Thaler Asset Management Inc. boosted its holdings in Option Care Health by 30.8% in the first quarter. Fuller & Thaler Asset Management Inc. now owns 4,204,481 shares of the company's stock worth $146,947,000 after acquiring an additional 989,048 shares in the last quarter. 98.05% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

OPCH has been the subject of several recent analyst reports. JMP Securities boosted their price target on Option Care Health from $36.00 to $38.00 and gave the stock a "market outperform" rating in a research note on Thursday, July 31st. Citigroup reiterated an "outperform" rating on shares of Option Care Health in a research report on Thursday, July 31st. Finally, Barrington Research reaffirmed an "outperform" rating and issued a $38.00 price objective on shares of Option Care Health in a research note on Thursday, July 10th. Eight investment analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the stock. Based on data from MarketBeat.com, Option Care Health currently has an average rating of "Moderate Buy" and an average price target of $35.75.

Insider Buying and Selling

In other news, Director Timothy P. Sullivan acquired 20,000 shares of Option Care Health stock in a transaction on Thursday, August 21st. The shares were bought at an average cost of $27.51 per share, for a total transaction of $550,200.00. Following the acquisition, the director directly owned 49,229 shares of the company's stock, valued at $1,354,289.79. This trade represents a 68.43% increase in their position. The purchase was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, Director Norman L. Wright acquired 3,411 shares of Option Care Health stock in a transaction on Tuesday, September 9th. The shares were purchased at an average price of $29.31 per share, for a total transaction of $99,976.41. Following the completion of the acquisition, the director directly owned 15,501 shares in the company, valued at $454,334.31. This trade represents a 28.21% increase in their ownership of the stock. The disclosure for this purchase can be found here. In the last three months, insiders acquired 59,411 shares of company stock valued at $1,627,576. Insiders own 0.64% of the company's stock.

Option Care Health Trading Down 0.7%

Shares of OPCH stock traded down $0.19 on Friday, reaching $28.22. 693,280 shares of the company's stock were exchanged, compared to its average volume of 1,841,223. Option Care Health, Inc. has a 52 week low of $21.39 and a 52 week high of $35.53. The company has a current ratio of 1.52, a quick ratio of 1.00 and a debt-to-equity ratio of 0.81. The stock has a market capitalization of $4.58 billion, a PE ratio of 22.58, a P/E/G ratio of 1.71 and a beta of 0.82. The company's fifty day simple moving average is $28.87 and its 200 day simple moving average is $31.29.

Option Care Health (NASDAQ:OPCH - Get Free Report) last issued its quarterly earnings results on Wednesday, July 30th. The company reported $0.41 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.40 by $0.01. Option Care Health had a return on equity of 17.53% and a net margin of 3.93%.The firm had revenue of $1.42 billion during the quarter, compared to analyst estimates of $1.35 billion. During the same period last year, the company earned $0.30 EPS. Option Care Health's quarterly revenue was up 15.4% compared to the same quarter last year. Option Care Health has set its FY 2025 guidance at 1.650-1.720 EPS. As a group, analysts forecast that Option Care Health, Inc. will post 1.22 EPS for the current year.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.